共 50 条
- [21] Phase II Trial of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2023, 142Nadeem, OmarMagidson, SophieRedd, Robert A.Laubach, JacobMo, Clifton C.O'Donnell, Elizabeth K.Sperling, Adam S.Hartley-Brown, Monique A.Midha, ShonaliMarto, MarjorieDavie, ChristineRicciardi, CarolineChoden, DechenStrutevant, AshleeAlberti, JillianTrippa, LorenzoMunshi, Nikhil C.Anderson, Kenneth C.Richardson, Paul G.Ghobrial, Irene M.
- [22] Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2016, 128 (22)Ghobrial, Irene M.Badros, Ashraf Z.Vredenburgh, James J.Matous, JeffreyCaola, Aaron M.Savell, AlexandraHenrick, PatrickPaba-Prada, Claudia E.Schlossman, Robert L.Laubach, Jacob P.Rosenblatt, JacalynYee, AndrewWisch, Jeffrey S.Farber, Charles M.Maegawa, Rodrigo O.Usmani, Saad Z.Cappuccio, JosephRivotto, BradleyNoonan, KimberlyReyes, KaitlenMunshi, Nikhil C.Anderson, Kenneth C.Richardson, Paul
- [23] PHASE II TRIAL OF COMBINATION OF ELOTUZUMAB, LENALIDOMIDE, AND DEXAMETHASONE IN HIGH-RISK SMOLDERING MULTIPLE MYELOMAHAEMATOLOGICA, 2017, 102 : 317 - 317Ghobrial, I.Caola, A.Henrick, P.Savell, A.Cappuccio, J.Rivotto, B.Reyes, K.Paba-Prada, C.Schlossman, R.Laubach, J.Richardson, P.Noonan, K.Munshi, N.Liu, C-J.Bustoros, M.Badros, A.Matous, J.Rosenblatt, J.Yee, A.Maegawa, R.Usmani, S.Vredenburgh, J.Boruchov, A.Nadeem, O.Bhutani, D.Jakubowiak, A.Bhutani, M.Salem, K.Manier, S.Park, J.
- [24] Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in high-risk smoldering multiple myelomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S89 - S89Nadeem, OmarRedd, RobertMo, CliftonLaubach, JacobRichardson, Paul G.Prescott, JuliaMarto, MarjorieDavie, ChristineRicciardi, CarolineMurphy, ElizabethBertoni, MeredithChoden, DechenMagidson, SophieSheehan, BrianShrestha, HiraSperling, Adam S.O'Donnell, Elizabeth K.Ghobrial, Irene M.
- [25] A Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2021, 138Nadeem, OmarReed, Robert A.Prescott, JuliaTague, KelseyRomines, VeronicaMetivier, AmadaSavell, AlexandraLeblebjian, HouryDistaso, AlexandraMo, Clifton C.Laubach, Jacob P.Sperling, Adam S.Richardson, Paul G.Ghobrial, Irene M.
- [26] Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2019, 134Bustoros, MarkNadeem, OmarSperling, Adam S.Bianchi, GiadaArdente, LilyRedd, Robert A.Prescott, JuliaFrey, ErinGuimond, KathleenStyles, RachelHornburg, KalvisSavell, AlexandraSu, Nang KhamBindra, GovindBoehner, Cody J.Reyes, KaitlenLeblebjian, HouryWarren, DianeMunshi, Nikhil C.Laubach, Jacob P.Anderson, Kenneth C.Richardson, Paul G.Ghobrial, Irene M.
- [27] Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2018, 132Bustoros, MarkLiu, Chia-jenReyes, KaitlenHornburg, KalvisGuimond, KathleenStyles, RachelSavell, AlexandraBerrios, BriannaWarren, DianeDumke, HenryRivotto, BradleyHenrick, PatrickScranton, EmilyLeblebjian, HouryMeid, KirstenSchlossman, Robert L.Munshi, NikhilLaubach, JacobAnderson, Kenneth C.Richardson, PaulGhobrial, Irene M.
- [28] Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple MyelomaBLOOD, 2018, 132Liu, Chia-JenGhobrial, Irene M.Bustoros, MarkReyes, KaitlenHornburg, KalvisBadros, Ashraf Z.Vredenburgh, James J.Boruchov, AdamMatous, Jeffrey V.Caola, AaronRivotto, BradleySavell, AlexandraHenrick, PatrickPaba-Prada, Claudia E.Schlossman, Robert L.Laubach, JacobRosenblatt, JacalynYee, Andrew J.Nadeem, OmarMaegawa, Rodrigo O.Jakubowiak, AndrzejUsmani, Saad Z.Bhutani, ManishaCappuccio, JosephBerrios, BriannaNoonan, KimberlyZavidij, OksanaMouhieddine, Tarek H.Boehner, Cody J.Neuse, Carl-JannesSalem, Karma ZiadReidy, MaireadPark, JihyeAgius, MichaelRahmat, MahshidManier, SalomonBhutani, DivayaZonder, Jeffrey A.Munshi, NikhilAuclair, DanielAnderson, KennethRichardson, Paul
- [29] Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple MyelomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 558 - 562Bilotti, ElizabethVesole, David H.McBride, LauraSchmidt, LindaGao, ZhijieGilani, MadihaMcNeill, AnnBednarz, UrszulaRichter, JoshuaMato, AnthonyGraef, ThorstenSiegel, David S.
- [30] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple MyelomaBLOOD, 2011, 118 (21) : 1706 - 1706Richter, Joshua R.Bilotti, ElizabethMcBride, LauraSchmidt, LindaGao, ZhijieTufail, MadihaAnand, PalkaMcNeill, AnnBednarz, UrszulaGraef, ThorstenVesole, David H.Siegel, David S.